Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:16 am Sale |
2024-12-31 | 13G | Blueprint Medicines Corporation BPMC |
FMR CORP | 2,247,679 3.500% |
-2,100,632 (-48.31%) |
Filing History |
| 2024-11-14 1:22 pm Sale |
2024-09-30 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 5,387,267 8.500% |
-863,556 (-13.82%) |
Filing History |
| 2024-04-10 12:58 pm Purchase |
2024-03-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 6,250,823 10.200% |
815,206 (+15.00%) |
Filing History |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 5,435,617 8.900% |
1,136,327 (+26.43%) |
Filing History |
| 2024-02-09 08:35 am Sale |
2024-02-08 | 13G | Blueprint Medicines Corporation BPMC |
FMR CORP | 4,348,311 7.153% |
-324,800 (-6.95%) |
Filing History |
| 2024-02-08 10:11 am Sale |
2023-12-29 | 13G | Blueprint Medicines Corporation BPMC |
WELLINGTON MANAGEMENT CO LLP | 4,276,333 7.030% |
-727,095 (-14.53%) |
Filing History |
| 2024-01-24 09:46 am Purchase |
2023-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BLACKROCK INC BLK |
6,584,176 10.800% |
309,654 (+4.94%) |
Filing History |
| 2024-01-10 10:16 am Purchase |
2023-12-29 | 13G | Blueprint Medicines Corporation BPMC |
The Vanguard Group | 6,114,970 10.060% |
340,514 (+5.90%) |
Filing History |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Blueprint Medicines Corporation BPMC |
FMR CORP | 4,673,111 7.687% |
-4,301,434 (-47.93%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 4,299,290 7.200% |
-251,249 (-5.52%) |
Filing History |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Blueprint Medicines Corporation BPMC |
The Vanguard Group | 5,774,456 9.650% |
240,685 (+4.35%) |
Filing History |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | Blueprint Medicines Corporation BPMC |
FMR CORP | 8,974,545 14.999% |
2,941,866 (+48.77%) |
Filing History |
| 2023-02-06 2:49 pm Purchase |
2022-12-30 | 13G | Blueprint Medicines Corporation BPMC |
WELLINGTON MANAGEMENT CO LLP | 5,003,428 8.360% |
1,526,103 (+43.89%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BLACKROCK INC BLK |
6,274,522 10.500% |
0 (Unchanged) |
Filing History |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Blueprint Medicines Corporation BPMC |
BLACKROCK INC BLK |
6,274,522 10.500% |
281,919 (+4.70%) |
Filing History |
| 2022-11-09 3:21 pm Purchase |
2022-10-31 | 13G | Blueprint Medicines Corporation BPMC |
BLACKROCK INC BLK |
5,992,603 10.000% |
655,729 (+12.29%) |
Filing History |
| 2022-05-10 10:13 am Purchase |
2022-05-09 | 13G | Blueprint Medicines Corporation BPMC |
FMR CORP | 6,032,679 10.126% |
3,684,227 (+156.88%) |
Filing History |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Blueprint Medicines Corporation BPMC |
PRICE T ROWE ASSOCIATES INC | 4,550,539 7.700% |
862,773 (+23.40%) |
Filing History |
| 2022-02-09 3:33 pm Purchase |
2021-12-31 | 13G | Blueprint Medicines Corporation BPMC |
The Vanguard Group | 5,533,771 9.410% |
347,259 (+6.70%) |
Filing History |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Blueprint Medicines Corporation BPMC |
FMR CORP | 2,348,452 3.991% |
-1,841,923 (-43.96%) |
Filing History |